FTC Considering Workshop On Intellectual Property/Antitrust Drug Issues
The Federal Trade Commission staff is considering a workshop on pharmaceutical antitrust and intellectual property issues for later this year.
The Federal Trade Commission staff is considering a workshop on pharmaceutical antitrust and intellectual property issues for later this year.